These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21875862)

  • 1. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.
    Gold MR; Birgersdotter-Green U; Singh JP; Ellenbogen KA; Yu Y; Meyer TE; Seth M; Tchou PJ
    Eur Heart J; 2011 Oct; 32(20):2516-24. PubMed ID: 21875862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer Left Ventricular Electric Delay Reduces Mitral Regurgitation After Cardiac Resynchronization Therapy: Mechanistic Insights From the SMART-AV Study (SmartDelay Determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy).
    Chatterjee NA; Gold MR; Waggoner AD; Picard MH; Stein KM; Yu Y; Meyer TE; Wold N; Ellenbogen KA; Singh JP
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27906653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of measures of ventricular delay on cardiac resynchronization therapy response.
    Field ME; Yu N; Wold N; Gold MR
    Heart Rhythm; 2020 Apr; 17(4):615-620. PubMed ID: 31765805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of left ventricular electrical delay on AV optimization for cardiac resynchronization therapy.
    Gold MR; Yu Y; Singh JP; Stein KM; Birgersdotter-Green U; Meyer TE; Seth M; Ellenbogen KA
    Heart Rhythm; 2013 Jul; 10(7):988-93. PubMed ID: 23499621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local electrogram delay recorded from left ventricular lead at implant predicts response to cardiac resynchronization therapy: retrospective study with 1 year follow up.
    Polasek R; Kucera P; Nedbal P; Roubicek T; Belza T; Hanuliakova J; Horak D; Wichterle D; Kautzner J
    BMC Cardiovasc Disord; 2012 May; 12():34. PubMed ID: 22607487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrically vs. imaging-guided left ventricular lead placement in cardiac resynchronization therapy: a randomized controlled trial.
    Stephansen C; Sommer A; Kronborg MB; Jensen JM; Nørgaard BL; Gerdes C; Kristensen J; Jensen HK; Fyenbo DB; Bouchelouche K; Nielsen JC
    Europace; 2019 Sep; 21(9):1369-1377. PubMed ID: 31274152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.
    van Bommel RJ; Tanaka H; Delgado V; Bertini M; Borleffs CJ; Ajmone Marsan N; Holzmeister J; Ruschitzka F; Schalij MJ; Bax JJ; Gorcsan J
    Eur Heart J; 2010 Dec; 31(24):3054-62. PubMed ID: 20864484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between mechanical and electrical remodelling in patients with cardiac resynchronization implanted defibrillators.
    Lellouche N; De Diego C; Boyle NG; Wiener I; Akopyan G; Child JS; Shivkumar K
    Europace; 2011 Aug; 13(8):1180-7. PubMed ID: 21486911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy.
    van der Bijl P; Khidir M; Leung M; Mertens B; Ajmone Marsan N; Delgado V; Bax JJ
    Eur J Heart Fail; 2017 Sep; 19(9):1145-1151. PubMed ID: 28176418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of paced left ventricular dyssynchrony on left ventricular reverse remodeling after cardiac resynchronization therapy.
    Gauthey A; Willemen E; Lumens J; Ploux S; Bordachar P; Ritter P; Prinzen FW; Lejeune S; Pouleur AC; Garnir Q; Marchandise S; Scavée C; Wauters A; le Polain de Waroux JB
    J Cardiovasc Electrophysiol; 2020 Feb; 31(2):494-502. PubMed ID: 31908084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of left ventricular electrical delay on the acute hemodynamic response with cardiac resynchronization therapy.
    Gold MR; Leman RB; Wold N; Sturdivant JL; Yu Y
    J Cardiovasc Electrophysiol; 2014 Jun; 25(6):624-30. PubMed ID: 24446891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular electrical delay as a predictor of arrhythmias in patients with cardiac resynchronization implantable cardioverter defibrillator.
    Elsaid O; Gulati V; Tecson K; Friedman M; Kluger J
    Scand Cardiovasc J; 2018 Dec; 52(6):356-361. PubMed ID: 30570402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) study.
    Gold MR; Thébault C; Linde C; Abraham WT; Gerritse B; Ghio S; St John Sutton M; Daubert JC
    Circulation; 2012 Aug; 126(7):822-9. PubMed ID: 22781424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of mechanical activation, scar, and electrical timing on cardiac resynchronization therapy response and clinical outcomes.
    Bilchick KC; Kuruvilla S; Hamirani YS; Ramachandran R; Clarke SA; Parker KM; Stukenborg GJ; Mason P; Ferguson JD; Moorman JR; Malhotra R; Mangrum JM; Darby AE; Dimarco J; Holmes JW; Salerno M; Kramer CM; Epstein FH
    J Am Coll Cardiol; 2014 Apr; 63(16):1657-66. PubMed ID: 24583155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy.
    Kristiansen HM; Vollan G; Hovstad T; Keilegavlen H; Faerestrand S
    Eur Heart J Cardiovasc Imaging; 2012 Dec; 13(12):991-1000. PubMed ID: 22677455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can We Use the Intrinsic Left Ventricular Delay (QLV) to Optimize the Pacing Configuration for Cardiac Resynchronization Therapy With a Quadripolar Left Ventricular Lead?
    van Everdingen WM; Zweerink A; Cramer MJ; Doevendans PA; Nguyên UC; van Rossum AC; Prinzen FW; Vernooy K; Allaart CP; Meine M
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005912. PubMed ID: 29874169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. His-Optimized Cardiac Resynchronization Therapy to Maximize Electrical Resynchronization: A Feasibility Study.
    Vijayaraman P; Herweg B; Ellenbogen KA; Gajek J
    Circ Arrhythm Electrophysiol; 2019 Feb; 12(2):e006934. PubMed ID: 30681348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyssynchrony and the risk of ventricular arrhythmias.
    Kutyifa V; Pouleur AC; Knappe D; Al-Ahmad A; Gibinski M; Wang PJ; McNitt S; Merkely B; Goldenberg I; Solomon SD; Moss AJ; Zareba W
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):432-44. PubMed ID: 23579010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer inter-lead electrical delay is associated with response to cardiac resynchronization therapy in patients with presumed optimal left ventricular lead position.
    Sommer A; Kronborg MB; Nørgaard BL; Stephansen C; Poulsen SH; Kristensen J; Gerdes C; Nielsen JC
    Europace; 2018 Oct; 20(10):1630-1637. PubMed ID: 29377984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.